VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESMO 2021 | Highlights in breast cancer from ESMO 2021

Cristina Saura Manich, MD, PhD, Vall d’Hebron Institute of Oncology, Barcelona, Spain, comments on key clinical trials presented at ESMO 2021, namely the DESTINY-Breast03 study (NCT03529110), the MONALEESA-2 trial (NCT01958021) and the KEYNOTE-522 trial (NCT03036488). This interview took place at the European Society for Medical Oncology (ESMO) 2021 congress.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter